Compare Adaptive Biotechnologies Corp (ADPT) vs Star Bulk Carriers Corp (SBLK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Adaptive Biotechnologies Corp vs Star Bulk Carriers Corp — how do they compare? Adaptive Biotechnologies Corp trades at $25.11 (market cap $4.04B), while Star Bulk Carriers Corp trades at $27.88 (market cap $3.09B). The key difference: Adaptive Biotechnologies Corp is the larger of the two by market cap, and Star Bulk Carriers Corp pays a 6.79% dividend while Adaptive Biotechnologies Corp pays none. Which is the better fit depends on your goals.
| ADPT | SBLK | |
|---|---|---|
Market Cap | $4.04B | $3.09B |
Sector | Health | Industrials |
52-Week High | $25.45 | $29.15 |
52-Week Low | $12.30 | $16.79 |
Enterprise Value | $4.10B | $3.77B |
Dividend Yield | — | 6.79% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ADPT trades at $25.45, up 2.09% today, near its 52-week high. The stock shows bullish technical signals with support at $25 and resistance at $26. Revenue growth accelerated to $277M in 2025, though net losses persist. Recent news highlights a strategic separation of its MRD and Immune Medicine businesses, aiming to unlock value.
Outlook is cautiously optimistic with 65% analyst buy ratings and a $25.50 price target. Key opportunities include MRD segment profitability and separation benefits, while risks involve sustained losses, competitive pressures, and execution challenges in the business split.
Star Bulk Carriers (SBLK) trades at $27.80, down 2.18% on the day, with a bullish technical signal from moving averages and strong quarterly earnings beats. The company reported robust Q2 2026 results with net income of $144.9 million and declared a $0.90 dividend, reflecting operational strength. Revenue grew to $1.2 billion in 2026, with net profit margin expanding to 23.86%, while valuation ratios like P/E of 10.85 and EV/EBITDA of 7.46 suggest reasonable pricing. Recent news highlights termination of a vessel agreement with Diana Shipping, but operational updates remain positive.
SBLK presents a favorable outlook with earnings momentum, high dividend yield, and analyst buy consensus, though risks include dry bulk rate volatility and competitive pressures. The stock's fundamental health supports potential upside, but investors should weigh cyclical industry exposure against strong cash flow generation and balance sheet flexibility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Adaptive Biotechnologies Corp
Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers.
Read more on ADPT →About Star Bulk Carriers Corp
Star Bulk Carriers Corp. is a global shipping company specializing in the seaborne transportation of dry bulk commodities. The company owns and operates a large fleet of bulk carriers, primarily transporting major commodities such as iron ore, coal, and grain. SBLK focuses on the Capesize, Post Panamax, and Kamsarmax vessel segments, providing critical logistical services to commodity producers and consumers worldwide.
Read more on SBLK →
